Background: Certain sensations are the secondary phenotypes of rosacea and affect patients' quality of life. Transient receptor potential (TRP) channels may be involved in its occurrence. However, there is a lack of research independently discussing itch in rosacea.
Objectives: Our study aimed to investigate risk factors for pruritus in rosacea patients and to discover the molecular mechanism of pruritus.
Methods: A binary logistic regression model was used to identify significant variables affecting pruritus in 782 rosacea patients. The LL-37 was injected intradermally into the face of mice to establish the animal model. qRT-PCR, immunohistochemistry and immunofluorescence were used to analyse the expression differences in pruritus-related molecules in mouse skin and the corresponding trigeminal ganglion (TG) between pruritus and nonpruritus groups.
Results: The incidence of pruritus in rosacea was 42.46%, and the incidence of other symptoms increased with pruritus. Temperature effects were prominently related to the itch sensation of rosacea. Intradermal injection of LL-37 not only caused rosacea-like facial lesions but also induced a behavioural pattern indicative of pruritus. Increased expression of the temperature-sensitive receptors TRPV4 and TRPM8 was found in pruritic mouse skin and TG and human skin samples.
Conclusions: In rosacea patients, pruritus occurs frequently along with burning, flushing and sensitivity, most likely due to changes in temperature. The temperature-sensitive receptors TRPV4 and TRPM8 are both involved in the mechanism of pruritus in rosacea.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jdermsci.2022.11.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study.
Photodiagnosis Photodyn Ther
January 2025
Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China. Electronic address:
Background: Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions.
Objectives: This study aimed to assess the effectiveness and safety of STBF-PDT for the treatment of moderate-to-severe rosacea.
Methods: In this prospective, randomised, evaluator-blind controlled study, patients with moderate-to-severe rosacea were assigned to receive up to six STBF-PDT sessions or 100 mg of doxycycline daily for eight weeks, followed by a 24-week follow-up.
Tetracyclines Revisited: Tetracyclines in the Field of Dermatology.
Dermatology
December 2024
Department of Dermatology, Incheon St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
Article Synopsis
- * The review discusses various conditions such as hidradenitis suppurativa, vitiligo, and atopic dermatitis, highlighting the diverse applications of tetracyclines in dermatology.
- * It also examines sarecycline, a new narrow-spectrum tetracycline, emphasizing its clinical effectiveness and potential effects on the microbiome, advocating for a broader use of tetracyclines in treating skin disorders.
Usability evaluation and reporting for mobile health apps targeting patients with skin diseases: a systematic review.
Clin Exp Dermatol
October 2024
Oxford University Hospitals NHS Foundation Hospitals, Dermatology Department, Churchill Hospital, Headington, Oxford, UK.
Article Synopsis
- Usability is crucial for mobile health apps, especially for skin disease patients, yet many apps lack proper design and evaluation.
- The study analyzed the usability of 9 mobile health apps, finding that most were easy to use and effective, with major concerns around navigation, security, and customizability.
- Acknowledging the gap between rapid app development and limited usability research, the study calls for improved user-centered design and thorough evaluation to enhance the adoption of these health apps.
Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis.
Life (Basel)
September 2024
Department of Otorhinolaryngology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Article Synopsis
- Abrocitinib is a JAK1 inhibitor mainly approved for treating moderate-to-severe atopic dermatitis in those 12 and older, but this review explores its off-label uses.
- Researchers found 37 studies using Abrocitinib for conditions beyond atopic dermatitis, with common cases including vitiligo, prurigo nodularis, and hand eczema, each having 12 reported instances.
- All but one of the 103 patients studied experienced favorable outcomes with Abrocitinib, highlighting its potential for treating multiple skin conditions.
Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases.
J Eur Acad Dermatol Venereol
July 2024
School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong.
Chronic spontaneous urticaria (CSU), atopic dermatitis (AD), psoriasis and rosacea are highly prevalent inflammatory skin conditions which impose a significant burden on patients' quality of life. Their pathophysiology is likely multifactorial, involving genetic, immune and environmental factors. Recent advancements in the field have demonstrated the key role of mast cells (MC) in the pathophysiology of these conditions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!